FTC alleges Precision Patient Outcomes changed the name of its product from COVID Resist to VIRUS Resist after the agency questioned advertising claiming it’s treatment for COVID-19. • Source: Federal Trade Commission
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
